Can we exonerate GLP-1 receptor agonists from blame for adverse pancreatic events? - Wikidata - awgldk - TriplyDB

Can we exonerate GLP-1 receptor agonists from blame for adverse pancreatic events?

Can we exonerate GLP-1 receptor agonists from blame for adverse pancreatic events?

http://www.wikidata.org/entity/Q55475796

about

Can we exonerate GLP-1 receptor agonists from blame for adverse pancreatic events?

http://www.wikidata.org/entity/Q55475796

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Can we exonerate GLP-1 receptor agonists from blame for adverse pancreatic events?

@en

Can we exonerate GLP-1 receptor agonists from blame for adverse pancreatic events?

@nl

type

label

Can we exonerate GLP-1 receptor agonists from blame for adverse pancreatic events?

@en

Can we exonerate GLP-1 receptor agonists from blame for adverse pancreatic events?

@nl

prefLabel

Can we exonerate GLP-1 receptor agonists from blame for adverse pancreatic events?

@en

Can we exonerate GLP-1 receptor agonists from blame for adverse pancreatic events?

@nl

P1433

Q55475796-0B4F8965-D3F5-463E-86E6-AC9141C98E21

P1476

Q55475796-7CB67076-985E-43CA-B569-CDE78749049F

P2093

Q55475796-6CF751F3-8F98-4A0B-927A-060793769C75

Q55475796-E52E7265-D2EF-41F4-9426-521ABB1FCA68

P2860

Q55475796-0A942E77-69B9-48CA-B72A-AF40D2044CE7

Q55475796-0AC21BA6-AD8E-4140-BA6C-0059C5B37D09

Q55475796-1452BE5D-4263-41DD-B514-8CECB3D11D30

Q55475796-14A841FA-AE7E-417B-A4A6-19988A724600

Q55475796-26BFEA99-9B1E-4004-962D-E77F0F116320

Q55475796-30557CB5-C17C-4564-AEE1-0AE71572AAF4

Q55475796-3A06B5A5-9964-4C89-9BD8-3E7060993985

Q55475796-3AE438BE-02BC-415D-9054-D9D60F256F37

Q55475796-52E7184A-2068-454F-97AF-C49047FA7C88

Q55475796-5D1E0DBD-30A1-429D-B5D6-F46040B4C78C

P304

Q55475796-298DBA24-FF86-4229-95DF-7A76B58AE936

P31

Q55475796-3F85BE5C-44D3-4DCC-AA89-36C5F7178C21

Q55475796-7390417b-aae0-421d-a4a1-a38f0b195436

P356

Q55475796-CA96C473-F85B-4ACC-95CA-232A8167A052

P433

Q55475796-7B140AEE-8C2A-423E-BF4A-1816DF7AC9D7

P478

Q55475796-B827475D-5C9F-41D5-8404-1A032F907917

P577

Q55475796-BED0C377-9111-4708-BC58-84616B0125DC

P698

Q55475796-8B7CFD49-EC11-4DF4-A764-7C6122AAE9C7

P932

Q55475796-C558FB80-3F32-4E25-B910-A1CF515B7BAC

P356

P1433

Annals of translational medicine

P1476

Can we exonerate GLP-1 receptor agonists from blame for adverse pancreatic events?

@en

P2093

Carel W le Roux

http://www.w3.org/2001/XMLSchema#string

Conor F Murphy

http://www.w3.org/2001/XMLSchema#string

P2860

Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies

Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors

GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence

Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model.

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.

Is there a link between liraglutide and pancreatitis? A post hoc review of pooled and patient-level data from completed liraglutide type 2 diabetes clinical trials.

Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials.

The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis

A review on the association between glucagon-like peptide-1 receptor agonists and thyroid cancer

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

P304

186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/ATM.2018.03.06

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29951508

http://www.w3.org/2001/XMLSchema#string

P932

5994527

http://www.w3.org/2001/XMLSchema#string